Related Experiment Videos

Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin

C Ponvert1, D Ardelean-Jaby, A M Colin-Gorski

  • 1Department of Medicine, Paris VI University, Paediatric Pulmonology & Allergy Service, Sick Children Hospital, 149 rue de Sèvres, 75015, Paris, France. pneumo.allergo@nck.ap-hop-paris.fr

Vaccine
|September 6, 2001
PubMed

Insights

Skin tests and specific IgE tests accurately diagnose IgE-dependent hypersensitivity to pneumococcal vaccine in children reporting severe reactions. These diagnostic methods are valuable for identifying vaccine allergies.

Area of Science:

  • Immunology
  • Allergy and Clinical Immunology
  • Vaccinology

Background:

  • The 23-valent pneumococcal vaccine is generally safe, but severe hypersensitivity reactions can occur.
  • Accurate diagnosis of vaccine hypersensitivity is crucial for patient management and future vaccination strategies.

Observation:

  • A child experiencing severe anaphylaxis post-pneumococcal vaccination underwent skin testing (prick and intradermal) and a radioallergosorbent test (RAST) using pneumococcal vaccine and phenol.
  • Ten control children (one with uneventful vaccination, nine unvaccinated) were also tested.
  • Skin tests and RAST with the vaccine were positive in the anaphylactic child and negative in most controls.

Findings:

  • Positive skin tests and RAST with pneumococcal vaccine in the patient suggest IgE-mediated hypersensitivity.
  • A non-vaccinated child showed a weakly positive intradermal test with the vaccine but a negative RAST.
  • All subjects had negative skin tests and RAST with phenol, ruling out phenol as a sensitizer.

Implications:

  • Immediate hypersensitivity reactions to pneumococcal vaccine can be diagnosed using skin tests and specific IgE determination.
  • These diagnostic tools demonstrate good value in identifying children with suspected IgE-dependent hypersensitivity to pneumococcal vaccines.
  • Findings support the utility of allergy testing in evaluating severe adverse events following pneumococcal vaccination.

Related Concept Videos